The effectiveness of EBC-46 is limited, however, to the early stages of tumorous growth. Metastatic cancers are still too far spread for topical treatment. Furthermore, the Blushwood tree is very rare and hard to cultivate. Several other teams are working on refining the production of the drug for large-scale distribution. Once perfected, nothing will stand in its way.